DEFLAZACORT DEFLAZACORT DEFLAZACORT DEFLAZACORT DEFLAZACORT DEFLAZACORT
DEFLAZACORT
DEFLAZACORT DEFLAZACORT DEFLAZACORT DEFLAZACORT DEFLAZACORT

DEFLAZACORT

80000 INR/Kilograms

Product Details:

  • Storage Room Temperature
  • Structural Formula C25H31NO6
  • HS Code 29420090
  • Smell Other
  • Melting Point 254 to 260C
  • Shelf Life 3 Years
  • Molecular Weight 441.517 g/mol Grams (g)
  • Click to View more
X

DEFLAZACORT Price And Quantity

  • 1 Kilograms
  • 80000 INR/Kilograms

DEFLAZACORT Product Specifications

  • Soluble in Dimethyl Formamide, slightly soluble in methanol, sparingly soluble in methylene chloride, practically insoluble in water and in light petroleum.
  • Other
  • less than or equal to 50 micrometers
  • Medicine Grade
  • 99 %
  • (11,16)-21-(Acetyloxy)-11-hydroxy-2-methyl-5H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
  • Powder
  • 544.2 C
  • NA
  • 390.01
  • NA
  • 14484-47-0
  • 238-483-7
  • Deflazacort is one type of medication which is used to reducing inflammation (swelling) and by changing the way the immune system works.
  • C25H31NO6
  • Room Temperature
  • Other
  • DEFLAZACORT
  • C25H31NO6
  • 29420090
  • Other
  • White to Off-White Solid
  • 254 to 260C
  • 3 Years
  • 441.517 g/mol Grams (g)

DEFLAZACORT Trade Information

  • INDIA
  • Cash Advance (CA), Cheque
  • 100 Kilograms Per Month
  • 1 Days
  • No
  • HDPE DRUM WITH TWO INNER LDPE LINNER
  • All India
  • GMP, FDCA

Product Description

is leadingmanufacturer and distributer of the Deflazacort among theother countries. Niksan Pharmaceutical is one of the major the supplier,distributer, exporter and manufacturer of the Deflazacort API andfinished formulations in Ankleshwar, Gujarat, India. The products of NiksanPharmaceutical and Niksan group companies are widely appreciated by the clientsand other companies.

 

Niksan Pharmaceutical is the supplier,manufacturer, exporter and trader of Deflazacort in thedomestic level as well as the international market. 

 

Niksan Pharmaceutical provides Deflazacort API in all over Indian states like Jammu & Kashmir,Himachal Pradesh, Uttarakhand, Punjab, Kerala, Chandigarh, Chhattisgarh, AndhraPradesh, Rajasthan, Meghalaya,Mizoram, Nagaland, Orissa,, Dadra and NagarHaveli, Goa, Gujarat,Jharkhand, West Bengal, Karnataka, Kerala, Madhya Pradesh etc.

 

Niksan Pharmaceutical also provides Deflazacort API and finishedformulations in all other countries of the world like Germany, Switzerland,Poland, Latvia, Egypt, Lithuania, Estonia, Ukraine, Moldova, Russia, UnitedStates, Austria, Belarus, Serbia, India, Spain, Slovenia, Nigeria, Croatia,South Africa, Kazakhstan, Italy, Romania, Bulgaria, Portugal, South Korea, Greece,Philippines, Belgium, Saudi Arabia, Turkey, Japan etc.

Deflazacort is one typeof medication which is used to reducing inflammation (swelling) and by changing the way theimmune system works.

 

SYNONYMS: Deflazacort

 

IUPAC NAME:[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl]acetate

 

CAS NO: 14484-47-0

 

FORMULA: C25H31NO6

 

MOLECULAR MASS:441.517 g/mol

 

STORAGE OF DEFLAZACORT:Store it at room temperature (25°C).

APPLICATIONS OF DEFLAZACORT: Deflazacort is used to treat Duchenne muscular dystrophy (DMD; a progressive disease in which the musclesdo not function properly) in adults and children 2 years of age and older. Deflazacortis in a class of medications called corticosteroids.

HOW TO USE: Deflazacort comes as a tablet and asuspension (liquid) to take by mouth. It is usually taken once a day with orwithout food. Take deflazacort at around thesame time every day. Follow the directions on your prescription labelcarefully, and ask your doctor or pharmacist to explain any part you do notunderstand.HOW DEFLAZACORT WORKS: It works by reducing inflammation (swelling) andby changing the way the immune system works.

CONTRAINDICATIONSOF DEFLAZACORT: If you are allergic to deflazacort or similarmedicines.

If you have an infectionand you are not taking any anti-infective medicine. If you are having orrecently had any vaccination with a live vaccine. Taking deflazacort during earlypregnancy may increase the risk of cleft lip and palate in a newborn.  

PHARMACOKINETICS OF DEFLAZACORT: Deflazacort is a corticosteroid prodrug with an activemetabolite, 21-deflazacort, which binds to the glucocorticoid receptor to exertanti-inflammatory and immunosuppressive effects on the body.

SIDE EFFECTS OF DEFLAZACORTheadache, thin, fragile skin, red or purple blotches or lines under theskin, increased hair growth, acne, bulging eyes, irregular or absent menstrualperiods, slowed healing of cuts and bruises.

 

PRECAUTIONS: This medicine may increase your risk of developingblood clots. Check with your doctor right awayif you or your child have swelling and pain in your arms, legs, or stomach,chest pain, shortness of breath, loss of sensation, confusion, or problems withmuscle control or speech.

 

CDSCO APPROVAL:

Deflazacort Oral Suspension are approvedby CDSCO in India in 15.06.07

 

FORMULATION AVAILABLEIN MARKET:

Deflazacort Tablet 1 MG 

Deflazacort Tablet 6 MG 

Deflazacort Tablet 18 MG  

Deflazacort Syrup

Deflazacort Oral Suspension (6 MG/5ML) 

 

 

Note: Product protected by validpatents are not offered for sale in countries where such patents are stillvalid and its liability is at Buyers Risk

 

REFERENCES:

 

www.webmd.com

https://pubchem.ncbi.nlm.nih.gov

https://go.drugbank.com

https://cdscoonline.gov.in

https://www.wikipedia.org/

https://www.drugs.com

https://www.zaubacorp.com

https://www.practo.com/consult

 


Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category



trade india member
NIKSAN PHARMACEUTICAL All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.